Inhibition of DAGLβ as a therapeutic target for pain in sickle cell disease
Sickle cell disease (SCD) is the most common inherited disease. Pain is a key morbidity of SCD and opioids are the main treatment but their side effects emphasize the need for new analgesic approaches. Humanized transgenic mouse models have been instructive in understanding the pathobiology of SCD...
Сохранить в:
| Главные авторы: | , , , , , , , , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Ferrata Storti Foundation
2022-05-01
|
| Серии: | Haematologica |
| Online-ссылка: | https://haematologica.org/article/view/10659 |
| Метки: |
Нет меток, Требуется 1-ая метка записи!
|